Your browser doesn't support javascript.
loading
Phase II trial of bevacizumab with dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer.
Fleming, Nicole D; Coleman, Robert L; Tung, Celestine; Westin, Shannon N; Hu, Wei; Sun, Yunjie; Bhosale, Priya; Munsell, Mark F; Sood, Anil K.
Afiliación
  • Fleming ND; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States. Electronic address: nfleming@mdanderson.org.
  • Coleman RL; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
  • Tung C; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX 77030, United States.
  • Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
  • Hu W; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
  • Sun Y; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
  • Bhosale P; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
  • Munsell MF; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
  • Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
Gynecol Oncol ; 147(1): 41-46, 2017 10.
Article en En | MEDLINE | ID: mdl-28774461
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Protocolos de Quimioterapia Combinada Antineoplásica / Inhibidores de la Angiogénesis Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Protocolos de Quimioterapia Combinada Antineoplásica / Inhibidores de la Angiogénesis Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2017 Tipo del documento: Article